Optimization of Triarylpyridinone Inhibitors of the Main Protease of SARS-CoV-2 to Low-Nanomolar Antiviral Potency.
Zhang CH, Spasov KA, Reilly RA, Hollander K, Stone EA, Ippolito JA, Liosi ME, Deshmukh MG, Tirado-Rives J, Zhang S, Liang Z, Miller SJ, Isaacs F, Lindenbach BD, Anderson KS, Jorgensen WL.
Zhang CH, et al. Among authors: liosi me.
ACS Med Chem Lett. 2021 Jul 14;12(8):1325-1332. doi: 10.1021/acsmedchemlett.1c00326. eCollection 2021 Aug 12.
ACS Med Chem Lett. 2021.
PMID: 34408808
Free PMC article.